Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan

Journal of Gastroenterology

Volumn 49, Issue 1, 2014, Pages 1-8

  Asaka, Masahiro ^a   Kato, Mototsugu ^b   Sakamoto, Naoya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Elimination of gastric cancer; Eradication of Helicobacter pylori; Gastric cancer; Helicobacter pylori

Indexed keywords

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; EARLY DETECTION OF CANCER; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INSURANCE, HEALTH; JAPAN; POPULATION SURVEILLANCE; STOMACH NEOPLASMS;

EID: 84895077019     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0897-8     Document Type: Review

References (47)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273-5.
2. International agency for research on cancer. World Health Organization: schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risk Hum. 1994;61:177-241.
3. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392-7.
4. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
5. Marugame T, Matsuda T, Kamo K, et al. Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol. 2007;37:884-91.
6. Nagayo T, Ito M, Yokoyama H, Komgoe T. Early phases of human gastric cancer: morphological study. Gann. 1965;56:101-20.
7. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann. 1968;59:251-8.
8. Kaneko E, Nakamura T, Umeda N, Fujino M, Niwa H. Outcome of gastric carcinoma detected by gastric mass survey in Japan. Gut. 1977;18:626-30.
9. Noguchi Y, Yoshikawa T, Tsuburaya A, et al. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89(11):2237-46.
10. Hundahl SA, Phillips JL, Menck HR. The national cancer data base report on poor survival of US gastric carcinoma patients with gastrectomy. Cancer. 2000;88:921-32.
11. Comparison of 5 year's survival rates between Japan and Western countries. Cancer Statistics in Japan-2006, 2006; pp 59.
12. Schlemper RJ, Itabashi M, Kato Y, et al. Difference in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet. 1997;349:1725-9.
13. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47(2):251-5.
14. Yamada H, Ikegami M, Shimoda T, et al. Long-term follow-up study of gastric adenoma/dysplasia. Endoscopy. 2004;36:390-6.
15. Park SY, Jeon SW, Jung MK, et al. Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma. Eur J Gastroenterol Hetatol. 2008;20:966-70.
16. Dinis-Ribeiro M, Areia M, De Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74-94.
17. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revised. Gut. 2002;51:130-1.
18. Miehlke S, Kirsch C, Dragosics B, et al. Helicobacter pylori and gastric cancer: current status of the Austrian Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol. 2001;7:243-7.
19. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187-94.
20. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer. 1994;73:2691-4.
21. Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378-81.
22. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
23. Arima N, Adachi K, Katsube T, et al. Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment. J Clin Gastroenterol. 1999;29:44-7.
24. Nasu J, Doi T, Endo H, Nishina T, et al. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy. 2005;37:990-3.
25. Wu CY, Kuo KN, Wu MS, et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009;137(5):1641-9.
26. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98:974-83.
27. Ma JL, Zhang L, Linda M, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer. 2012;104:488-92.
28. Maehata Y, Nakamura S, Fujisawa K, et al. Long-term follow-up study about preventive effect of H. pylori eradication for the incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc. 2012;75:39-46.
29. Kato M, Asaka M, Kikuchi S. Long-term follow-up study about preventive effect of H. pylori eradication for the Incidence of metachronous gastric cancer after endoscopic resection of primary early gastric cancer. Gastroenterology. 2012;142(5 Supple1):S3.
30. Harvard Report on Cancer Prevention. Volume 1: causes of human cancer. Cancer Causes Control. 1996;7(Suppl 1):S3-59.
31. Olsen JH, Andersen A, Dreyer L, et al. Summary of avoidable cancers in the Nordic countries. APMIS Suppl. 1997;76:141-6.
32. Number of incidence by cancer site 2007. Cancer statistics in Japan-2012, Tokyo, Japan 2012; pp 15.
33. Tsukuma H, Tanaka H, Ajiki W, Oshima A. Liver cancer and its prevention. Asian Pac J Cancer Prev. 2005;6:244-50.
34. Makuuchi M, Kokudo N, Arii S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38:37-51.
35. Trends in site-specific crude mortality rate 1965-2010. Cancer Statistics in Japan-2011, Tokyo, Japan, 2011; pp 26.
36. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1-20.
37. Blaser MJ. Gastric Campylobacter-like organism, gastritis, and peptic ulcer diseases. Gastroenterology. 1987;93:371-83.
38. Keates S, Hitti YS, Upton M, et al. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology. 1997;113:1099-109.
39. Asaka M, Sugiyama T, Nobuta A, et al. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter. 2001;6:294-9.
40. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992;52:6735-40.
41. Asaka M, Takeda H, Sugiyama T, et al. What role does Helicobacter pylori play in gastric cancer? Gastroenterology. 1997;113:S56-60.
42. Asaka M. A new approach for elimination of gastric cancer in Japan. Int J Cancer. 2013;132:1272-6.
43. Kodama M, Murakami K, Okimoto T, et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol. 2012;47:394-403.
44. Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter. 2010;15:486-90.
45. Akamatsu T, Ichikawa S, Okudaira S, et al. Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. J Gastroenterol. 2011;46:1353-60.
46. Murakami K, Furuta T, Ando T et al Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan. J Gastroenterol. 2013; 48 published online.
47. Patient survey 2011, Statistics and Information Department, Ministry of Health, Labour and welfare, 2011; pp 53.